Helicobacter pylori and NSAIDs--the end of the debate?

Affiliations

Comment

Roy E Pounder. Lancet. 2002.

. 2002 Jan 5;359(9300):3-4.

doi: 10.1016/S0140-6736(02)07267-7.

¹ Centre for Gastroenterology, Royal Free and University College Medical School, NW3 2QG, London, UK. r.pounder@rfc.ucl.ac.uk

No abstract available

Comment on

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.
Chan FK, To KF, Wu JC, Yung MY, Leung WK, Kwok T, Hui Y, Chan HL, Chan CS, Hui E, Woo J, Sung JJ. Chan FK, et al. Lancet. 2002 Jan 5;359(9300):9-13. doi: 10.1016/s0140-6736(02)07272-0. Lancet. 2002. PMID: 11809180 Clinical Trial.
Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
Huang JQ, Sridhar S, Hunt RH. Huang JQ, et al. Lancet. 2002 Jan 5;359(9300):14-22. doi: 10.1016/S0140-6736(02)07273-2. Lancet. 2002. PMID: 11809181